These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2856060)

  • 21. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
    Zatta A; Zanetti A; Dejana E; Prosdocimi M
    Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis.
    Chen CX; Jin RM; Li YK; Zhong J; Yue L; Chen SC; Zhou JY
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):126-30. PubMed ID: 1317985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?
    Benigni A; Livio M; Dodesini P; Schieppati A; Panigada M; Mecca G; de Gaetano G; Remuzzi G
    Am J Nephrol; 1985; 5(4):243-7. PubMed ID: 2996352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH; Ko FN; Kuo YH; Teng CM
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the effect of dopamine on the human platelet response.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):613-8. PubMed ID: 1382907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of labetalol on the arachidonic acid metabolism in human blood platelets, and in lung and aorta of the rat.
    Srivastava KC; Awasthi KK
    Prostaglandins Leukot Med; 1983 Sep; 12(1):1-9. PubMed ID: 6356152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA; Betterridge DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
    De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
    Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M
    Gen Pharmacol; 1991; 22(5):773-8. PubMed ID: 1684769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
    Ko FN; Yeh LJ; Liang HC; Kuo SC; Teng CM
    J Pharm Pharmacol; 1996 Apr; 48(4):395-400. PubMed ID: 8794990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of bupivacaine and pipecoloxylidide on platelet function in vitro.
    Odoom JA; Sturk A; Dokter PW; Bovill JG; ten Cate JW; Oosting J
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):385-8. PubMed ID: 2529732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and impairment of platelet function in vitro by fatty acid ethyl ester, a nonoxidative ethanol metabolite: effect of fatty acid ethyl esters on human platelets.
    Salem RO; Laposata M
    Alcohol Clin Exp Res; 2006 Dec; 30(12):2079-88. PubMed ID: 17117973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet effect of 2-(diethylamino)-7-hydroxychromone.
    Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M; Balbi A
    Pharmacol Res; 1991 Feb; 23(2):139-48. PubMed ID: 1648215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.